发明名称 |
CARDIAC GLYCOSIDE COMPOSITION |
摘要 |
The solubility of pharmaceuticals for application in gelatin capsules is increased by dissolving them in monoglycerides- and opt. diglycerides of 8-12C fatty acids. The process increases the reabsorption from the gastrointestinal tract and gives greater dosage accuracy. In an example, 1 ml. of fatty acid glyceride mixt. was used to dissolve (a) 5 mg. g-strophanthin; (b) 100 mg. benzanone; (c) 5 mg. digoxin. |
申请公布号 |
AU2692777(A) |
申请公布日期 |
1979.01.18 |
申请号 |
AU19770026927 |
申请日期 |
1977.07.11 |
申请人 |
KALI-CHEMIE PHARMA GMBH |
发明人 |
THEODOR ECKERT;FRITZ H. KEMPER;MARTIN WISCHNIEWSKI;REINHARD HEMPEL |
分类号 |
A61K9/107;A61K9/02;A61K9/48;A61K47/14 |
主分类号 |
A61K9/107 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|